Sanofi
About Sanofi
Categories
-
US -
2018On CPHI since
Sanofi Resources (7)
-
News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%
Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government. -
News Sanofi to accelerate mRNA vaccines through new Center of Excellence
The company will invest €400 million per year to advance mRNA technology beyond the pandemic -
News Sanofi secures FDA approval for additional flu vaccine manufacturing plant
Commercialisation activities for the US market are already underway for Fluzone High-Dose Quadrivalent -
News Sanofi to provide fill and finish manufacturing support for Moderna vaccine
French company is now providing manufacturing capacity to support three different COVID-19 vaccines -
News Sanofi strengthens vaccines manufacturing capacity in Singapore
The company will invest €400 million in a new site to enable it to produce vaccines on a massive scale for Asia -
News Sanofi and GSK to support COVAX with 200 million doses of COVID-19 vaccine
The companies anticipate first results of Phase I/II in early December 2020, to support the initiation of a pivotal Phase III study before the end of the year.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance